breast cancer

Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
BioSpace
Mon, 03/27/23 - 11:27 am
Novartis
clinical trials
Kisqali
breast cancer
Olema Oncology to cut 25% of staff, says it will focus on late-stage pipeline
Endpoints
Fri, 03/10/23 - 09:49 am
Olema Oncology
breast cancer
layoffs
OP-1250
FDA widens Lilly's Verzenio breast cancer reach, removes test and menopausal status demands
Fierce Pharma
Mon, 03/6/23 - 11:50 am
Eli Lilly
Verzenio
breast cancer
Aileron Terminates Phase 1b Breast Cancer Chemoprotection Trial Of ALRN-6924
NASDAQ
Tue, 02/21/23 - 04:34 pm
Aileron Therapeutics
clinical trials
breast cancer
ALRN-6924
Next phase of breast cancer vaccine research begins at Cleveland Clinic
WKYC
Thu, 02/9/23 - 10:31 am
breast cancer
vaccines
Cleveland Clinic
triple negative breast cancer
Gilead's Trodelvy snags vital breast cancer nod
Fierce Pharma
Mon, 02/6/23 - 10:44 am
Gilead Sciences
FDA
Trodelvy
breast cancer
HR-positive HER-negative breast cancer
In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion
Fierce Pharma
Tue, 01/31/23 - 11:11 pm
Pfizer
Ibrance
FDA
breast cancer
Menarini shows Big Pharma how it's done with first approval for oral SERD drug in breast cancer
Fierce Pharma
Mon, 01/30/23 - 05:50 pm
Menarini
Serds
oral SERDs
breast cancer
Orserdu
5 FDA decisions to watch in the first quarter
BioPharma Dive
Mon, 01/9/23 - 10:27 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Menareni
Elacestrant
breast cancer
Biomarin
Roctavian
hemophilia A
Acadia Pharmaceuticals
trofinetide
Rett Syndrome
Gilead Sciences
Trodelvy
FDA says yes to MedCognetics breast cancer screening AI
Pharmaphorum
Thu, 12/15/22 - 10:53 am
Medtech
digital health
MedCognetics
FDA
artificial intelligence
breast cancer
diagnostics
AstraZeneca-Daiichi Sankyo’s therapy shows response in breast cancer trials
Clinical Trials Arena
Mon, 12/12/22 - 10:26 am
AstraZeneca
Daiichi Sankyo
clinical trials
datopotamab deruxtecan
metastatic triple-negative breast cancer
breast cancer
SABCS: AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla
Fierce Pharma
Fri, 12/9/22 - 10:54 am
SABCS
AstraZeneca
Enhertu
breast cancer
Daiichi Sankyo
Roche
Kadcyla
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
Fri, 12/9/22 - 10:46 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Gilead Sciences
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model
BioSpace
Fri, 12/9/22 - 10:36 am
Myriad Genetics
diagnostics
genetic testing
breast cancer
RiskScore
Novartis’ Kisqali Hits Mark in Mid-Stage Breast Cancer Trial
BioSpace
Wed, 12/7/22 - 11:39 pm
Novartis
Kisqali
breast cancer
clinical trials
Carrick Therapeutics raises $60m for novel cancer treatments, including $35M from Pfizer
Silicon Republic
Fri, 12/2/22 - 11:02 am
Carrick Therapeutics
funding
breast cancer
Pfizer
Google Health licenses breast cancer detection AI to iCAD
Medtech Dive
Tue, 11/29/22 - 10:58 am
Medtech
diagnostics
Google Health
iCAD
artificial intelligence
breast cancer
mammography
The problem with Her2-low testing
EP Vantage
Mon, 11/28/22 - 07:34 pm
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
diagnostics
HER2-low breast cancer
Pfizer's $1B protein degradation bet yields 3% response rate in Arvinas' midphase breast cancer trial
Fierce Biotech
Tue, 11/22/22 - 11:00 am
Pfizer
protein degradation
Arvinas
clinical trials
breast cancer
ARV-471
Pfizer discards eczema, NASH and breast cancer programs in early-phase clean-out
Fierce Biotech
Tue, 11/1/22 - 12:09 pm
Pfizer
R&D
NASH
breast cancer
eczema

Pages